Mevis Medical Solutions AG
XETRA:M3V
Mevis Medical Solutions AG
XETRA:M3V
Price:
26.4 EUR
0.76%
Market Closed
Updated:
May 4, 2024
Mevis Medical Solutions AG
Cash from Financing Activities
|
Mevis Medical Solutions AG
Cash from Financing Activities Peer Comparison
Comparables:
COP
NXU
AJ91
IS8
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mevis Medical Solutions AG
XETRA:M3V
|
Cash from Financing Activities
-€4.5m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CompuGroup Medical SE & Co KgaA
XETRA:COP
|
Cash from Financing Activities
-€80.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Nexus AG
XETRA:NXU
|
Cash from Financing Activities
-€16.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-16%
|
|
|
DocCheck AG
XETRA:AJ91
|
Cash from Financing Activities
-€5.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Ifa Systems AG
XETRA:IS8
|
Cash from Financing Activities
-€506k
|
CAGR 3-Years
45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mevis Medical Solutions AG's Cash from Financing Activities?
Cash from Financing Activities
-4.5m
EUR
-4.5m
EUR
Based on the financial report for Sep 30, 2022, Mevis Medical Solutions AG's Cash from Financing Activities amounts to -4.5m EUR.
What is Mevis Medical Solutions AG's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-41%
-41%
Over the last year, the Cash from Financing Activities growth was 20%. The average annual Cash from Financing Activities growth rates for Mevis Medical Solutions AG have been -41% over the past three years .
You don't have any saved screeners yet
